Geneva Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
155,785
+37,713
| +32% | +$3.29M | 0.23% | 88 |
|
|
2025
Q1 | $8.06M | Buy |
118,072
+5,095
| +5% | +$348K | 0.15% | 92 |
|
|
2024
Q4 | $8.79M | Sell |
112,977
-17,691
| -14% | -$1.38M | 0.15% | 98 |
|
|
2024
Q3 | $8.76M | Buy |
130,668
+4,414
| +3% | +$296K | 0.15% | 99 |
|
|
2024
Q2 | $14.3M | Buy |
+126,254
| New | +$14.3M | 0.26% | 88 |
|